Our Diversity, Equity, and Inclusion (DE&I) Data Service can help sponsors improve diversity from the trial planning stage onwards by ensuring diverse patient cohorts that accurately reflect the patient population. As well as meeting new global DE&I rules from regulators, we can help you improve protocol design, minimize costly protocol amendments and bring more effective drugs to market, faster.
Phesi’s DE&I Data Service has been born out of a real need for a more innovative solution to address the lack of diversity in clinical trials. By leveraging Digital Patient Profiles (DPP) from our Trial Accelerator™ platform and Krystelis’ expertise in medical writing services we can help you ensure any therapeutic is efficacious for all intended patient populations.